Please use this identifier to cite or link to this item:
Title: Anthocyanin-rich red grape extract impedes adenoma development in the ApcMin mouse: Pharmacodynamic changes and anthocyanin levels in the murine biophase
Authors: Cai, Hong
Marczylo, Timothy H.
Teller, Nicole
Brown, Karen
Steward, William P.
Marko, Doris
Gescher, Andreas J.
First Published: 7-Jan-2010
Publisher: Elsevier
Citation: European Journal of Cancer, 2010, 46 (4), pp. 811-817.
Abstract: Purpose: Red grape pomace extract (oenocyanin) is a cheap and rich source of anthocyanins, the agents suggested to possess cancer chemopreventive properties. Here the hypothesis was tested that oenocyanin added to the diet can interfere with intestinal adenoma development in the ApcMin mouse, a model of intestinal carcinogenesis linked to an Apc mutation. Methods: Mice received oenocyanin (0.3%) in their diet until week 16, when adenoma number and burden were recorded. Expression of Akt and ERK proteins was studied by Western blot in adenomas to discover effects of anthocyanins on cellular signalling via the PI3 and MAP kinase pathways. Levels of anthocyanins were measured by HPLC with visible spectroscopic or mass spectrometric detection. Results: In mice which had consumed oenocyanin, overall adenoma burden was halved and adenoma number was marginally reduced when compared with mice on control diet. The proliferation index in colonic adenomatous crypts, as reflected by Ki-67 staining, was significantly decreased from 88.14% in control mice to 75.6 ± 4% in mice on oenocyanin (P = 0.014). Expression of Akt in small intestinal adenomas from ApcMin mice on oenocyanin was reduced by 54% (P = 0.003), when compared to controls. Oenocyanin anthocyanins and glucuronide metabolites were found in the urine and intestine but not in plasma. Conclusions: The results suggest that oenocyanin may be a viable and economical alternative to anthocyanin-rich berry extracts for chemopreventive intervention. Akt and pErk might be suitable biomarkers of anthocyanin target organ efficacy.
ISSN: 0959-8049
Type: Article
Description: This paper was published as European Journal of Cancer, 2010, 46 (4), pp. 811-817. It is available from DOI: 10.1016/j.ejca.2009.12.017
Metadata only entry
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.